Form 8-K - Current report:
SEC Accession No. 0001193125-21-310360
Filing Date
2021-10-28
Accepted
2021-10-28 07:15:59
Documents
14
Period of Report
2021-10-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d251657d8k.htm   iXBRL 8-K 24788
2 EX-99.1 d251657dex991.htm EX-99.1 12695
6 GRAPHIC g251657g1028011736728.jpg GRAPHIC 6110
  Complete submission text file 0001193125-21-310360.txt   173116

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hcwb-20211028.xsd EX-101.SCH 2904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hcwb-20211028_lab.xml EX-101.LAB 18123
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hcwb-20211028_pre.xml EX-101.PRE 11413
7 EXTRACTED XBRL INSTANCE DOCUMENT d251657d8k_htm.xml XML 3321
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 211355041
SIC: 2834 Pharmaceutical Preparations